| Year |
Citation |
Score |
| 2022 |
Dai L, Wang C, Wang W, Song K, Ye T, Zhu J, Di W. Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation. Open Medicine (Warsaw, Poland). 17: 229-238. PMID 35178477 DOI: 10.1515/med-2022-0422 |
0.323 |
|
| 2020 |
Song K, Dai L, Long X, Wang W, Di W. Follicle-stimulating hormone promotes the proliferation of epithelial ovarian cancer cells by activating sphingosine kinase. Scientific Reports. 10: 13834. PMID 32796926 DOI: 10.1038/s41598-020-70896-0 |
0.344 |
|
| 2019 |
Song K, Dai L, Long X, Cui X, Liu Y, Di W. Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo. Oncotargets and Therapy. 12: 4437-4449. PMID 31239712 DOI: 10.2147/OTT.S208519 |
0.373 |
|
| 2015 |
Dai L, Zhuang L, Zhang B, Wang F, Chen X, Xia C, Zhang B. DAG/PKCδ and IP3/Ca(2+)/CaMK IIβ Operate in Parallel to Each Other in PLCγ1-Driven Cell Proliferation and Migration of Human Gastric Adenocarcinoma Cells, through Akt/mTOR/S6 Pathway. International Journal of Molecular Sciences. 16: 28510-28522. PMID 26633375 DOI: 10.3390/ijms161226116 |
0.302 |
|
| 2015 |
Ding Q, Chen Y, Zhang Q, Guo Y, Huang Z, Dai L, Cao S. 8‑bromo‑7‑methoxychrysin induces apoptosis by regulating Akt/FOXO3a pathway in cisplatin‑sensitive and resistant ovarian cancer cells. Molecular Medicine Reports. PMID 26151347 DOI: 10.3892/mmr.2015.4039 |
0.308 |
|
| 2015 |
Liu C, Zeng Y, Dai LH, Cai TY, Zhu YM, Dou DQ, Ma LQ, Sun YX. Mogrol represents a novel leukemia therapeutic, via ERK and STAT3 inhibition. American Journal of Cancer Research. 5: 1308-18. PMID 26101699 |
0.356 |
|
| 2013 |
Zhang N, Dai L, Qi Y, Di W, Xia P. Combination of FTY720 with cisplatin exhibits antagonistic effects in ovarian cancer cells: role of autophagy. International Journal of Oncology. 42: 2053-9. PMID 23592281 DOI: 10.3892/ijo.2013.1906 |
0.325 |
|
| 2011 |
Dai L, He J, Liu Y, Byun J, Vivekanandan A, Pennathur S, Fan X, Lubman DM. Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor. Proteomics. 11: 4529-40. PMID 21932445 DOI: 10.1002/Pmic.201000730 |
0.632 |
|
| 2011 |
Dai L, Liu Y, He J, Flack CG, Talsma CE, Crowley JG, Muraszko KM, Fan X, Lubman DM. Differential profiling studies of N-linked glycoproteins in glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor. Proteomics. 11: 4021-8. PMID 21898824 DOI: 10.1002/Pmic.201100014 |
0.633 |
|
| 2010 |
Liu YH, Wang ZY, Dai L, Shen WH, Cen JN, Zhang W, Ruan CG. [Influence of arsenic trioxide and daunorubicin on the expression of annexin II and fibrinolytic activity in NB4 cells.] Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi. 31: 813-816. PMID 21223737 |
0.483 |
|
| 2010 |
Dai L, Li C, Shedden KA, Lee CJ, Li C, Quoc H, Simeone DM, Lubman DM. Quantitative proteomic profiling studies of pancreatic cancer stem cells. Journal of Proteome Research. 9: 3394-402. PMID 20486718 DOI: 10.1021/Pr100231M |
0.642 |
|
| 2009 |
Liu YH, Wang ZY, Zhang W, Dai L, Shen WH, Ruan CG. [Clinical study on the fibrinolytic activity in patients with acute promyelocytic leukemia]. Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi. 30: 145-9. PMID 19642359 |
0.422 |
|
| 2009 |
Dai L, Li C, Shedden KA, Misek DE, Lubman DM. Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis. Electrophoresis. 30: 1119-31. PMID 19288585 DOI: 10.1002/Elps.200800505 |
0.615 |
|
| Show low-probability matches. |